Publication date: Jul 22, 2024
Objective: Atrial fibrillation (AF) is a common arrhythmia in patients at high cardiovascular risk. COVID-19 patients with underlying cardiovascular disease are at increased risk of poor clinical outcomes. In this study, we aimed to determine hospital outcomes among patients admitted with AF and COVID -19 infection. Methods: We conducted a retrospective analysis using the 2020 California State Inpatient data, including all COVID-19 hospitalizations of individuals aged ≥18. Primary outcomes were in-hospital mortality, prolonged length of stay (above the 75 percentile), vasopressor use, mechanical ventilation, and ICU admission. We compared adverse hospital outcomes between those with and without AF and used multivariable logistic regression to adjust for confounders. Results: This analysis included 94,114 COVID-19 hospitalizations, of which 9,391 (10. 0%) had AF. Patients with COVID-19 and AF had higher rates of adverse outcomes, including mortality (27. 2% versus 9. 6%, P
| Concepts | Keywords |
|---|---|
| California | atrial fibrillation |
| Cardiovascular | COVID-19 |
| Hospitalizations | ICU admission |
| Poor | length of stay |
| mechanical ventilation | |
| mortality | |
| vasopressor use |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | atrial fibrillation |
| disease | MESH | COVID-19 |
| disease | MESH | arrhythmia |
| disease | MESH | cardiovascular disease |
| disease | MESH | infection |
| disease | MESH | Long Covid |